/CRSP

CRISPR Therapeutics AG

CRSP

$51.72USD↓-1.03%-0.54 today

MARKET CAP

5.0B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$52 – $53

52W RANGE

$44

$78

AI Summary

Stalk

Sell NowMedium

CRSP has broken decisively below its key horizontal support zone and 9/20 EMAs, confirming a medium-term bearish phase. Short-term momentum remains negative with price extended below EMAs and no signs of exhaustion. We will execute Sell Now on continued weakness, viewing any rally into the broken support zone as an opportunity to reinforce positions to the downside.

↑Q2 CASGEVY sales $76M (+151% YoY) drives strong growth.
↑Q2 revenue $10.2M vs $7M consensus; beat expectations.
↓Q2 loss of $0.94/sh vs $1.10 estimate highlights ongoing deficits.

Full analysis →

Buying

7

institutions

Selling

6

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	8.35 M	455.35 M	+668.90 K	+24.6%	0.01%
TR T. Rowe Price Investment Management, Inc. Q2 2026	SELL	2.05 M	111.97 M	+-899.58 K	-20.3%	0.07%
CA Citadel Advisors LLC Q2 2026	SELL	1.01 M	55.20 M	+-335.46 K	-13.9%	0.01%
JC Jpmorgan Chase & Co Q2 2026	SELL	431.67 K	24.57 M	+-25.97 K	+21.1%	0.00%
MM Millennium Management LLC Q2 2026	BUY	439.73 K	23.98 M	+62.55 K	+33.7%	0.01%
CP California Public Employees Retirement System Q2 2026	SELL	102.67 K	5.60 M	+-13.44 K	+1.4%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	BUY	101.65 K	5.54 M	+28.32 K	+58.9%	0.01%
FA Fisher Asset Management, LLC Q2 2026	BUYNEW	77.96 K	4.25 M	+77.96 K	+0.0%	0.00%
MG Man Group Plc Q2 2026	SELL	73.19 K	3.99 M	+-16.87 K	-6.8%	0.01%
JH Janus Henderson Group Plc Q1 2026	BUY	80.55 K	3.83 M	+45.77 K	+110.3%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	43.10 K	2.35 M	+-800.00	+12.6%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	28.60 K	1.56 M	+6.33 K	+47.2%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	BUY	12.46 K	679.51 K	+6.82 K	+153.4%	0.01%